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Most of the bone and cartilage in the craniofacial region is derived from cephalic neural crest cells, which undergo three
primary developmental events: migration from the rhombomeric neuroectoderm to the pharyngeal arches, proliferation as
the ectomesenchyme within the arches, and differentiation into terminal structures. Interactions between the ectomesen-
chymal cells and surrounding cells are required in these processes, in which defects can lead to craniofacial malformation.
We have previously shown that the G-protein-coupled endothelin-A receptor (ETA) is expressed in the neural crest-derived
ectomesenchyme, whereas the cognate ligand for ETA, endothelin-1 (ET-1), is expressed in arch epithelium and the paraxial
mesoderm-derived arch core; absence of either ETA or ET-1 results in numerous craniofacial defects. In this study we have
ttempted to define the point at which cephalic neural crest development is disrupted in ETA-deficient embryos. We find
hat, while neural crest cell migration in the head of ETA 2/2 embryos appears normal, expression of a number of
transcription factors in the arch ectomesenchymal cells is either absent or significantly reduced. These ETA-dependent
actors include the transcription factors goosecoid, Dlx-2, Dlx-3, dHAND, eHAND, and Barx1, but not MHox, Hoxa-2,
RABP1, or Ufd1. In addition, the size of the arches in E10.5 to E11.5 ETA 2/2 embryos is smaller and an increase in
ectomesenchymal apoptosis is observed. Thus, ETA signaling in ectomesenchymal cells appears to coordinate specific
aspects of arch development by inducing expression of transcription factors in the postmigratory ectomesenchyme. Absence
of these signals results in retarded arch growth, defects in proper differentiation, and, in some mesenchymal cells, apoptosis.
In particular, this developmental pathway appears distinct from the pathway that includes UFD1L, implicated as a causative
gene in CATCH 22 patients, and suggests parallel complementary pathways mediating craniofacial develop-
ment. © 2000 Academic Press











The pharyngeal arches are unique transient structures
that give rise to much of the head and neck skeleton
(Noden, 1988). They are populated early in development by
cephalic neural crest cells originating from the posterior
midbrain–hindbrain region in a precise rostral–caudal pat-
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Hughes Medical Institute, University of Texas Southwestern Medi-
cal Center, 5323 Harry Hines Blvd., Room Y5.210, Dallas, TXt75235-9050. Fax: (214) 648-5068. E-mail: afcsushi@aol.com.
10ern (Kontges and Lumsden, 1996; Lumsden et al., 1991;
erbedzija et al., 1992). During migration, these cells un-
ergo an epithelial to mesenchymal transition (Le Douarin,
982). These ectomesenchymal cells interact with epithe-
ial and mesodermal cell populations within the arches,
eading to the formation of craniofacial bones, cartilages,
nd connective tissues (Kontges and Lumsden, 1996; Le
ouarin, 1982; Noden, 1988). Proper spatiotemporal expres-
ion of transcription factors plays a crucial role in these
rocesses, both in guiding neural crest cells during their
igration and in orchestrating their subsequent differentia-ion (Francis-West et al., 1998).
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11Endothelin in Pharyngeal Arch DevelopmentWe have recently demonstrated that components of the
endothelin (ET) pathway are also involved in cephalic
neural crest cell development. One of the two known
G-protein-coupled endothelin receptors, ETA, is expressed
in the cephalic neural crest-derived ectomesenchyme of the
pharyngeal arches (Clouthier et al., 1998), while its primary
ligand, endothelin-1 (ET-1), is expressed in the arch ecto-
dermal epithelium, pharyngeal pouch endoderm, and arch
core paraxial mesoderm (Clouthier et al., 1998; Maemura et
al., 1996). Endothelin-converting enzyme-1 (ECE-1), which
proteolytically converts the inactive precursor of ET-1 to
the active form (Xu et al., 1994), is expressed at sites both
where ETA is expressed and where ET-1 is expressed
(Yanagisawa et al., 1998b). Targeted disruption of ETA
(Clouthier et al., 1998), ET-1 (Kurihara et al., 1994), or
ECE-1 (Yanagisawa et al., 1998b) in mice results in cranio-
facial defects that resemble the human condition termed
CATCH 22 (Wilson et al., 1993), characterized by abnormal
facies and cardiovascular defects. We have shown that the
craniofacial malformations observed in ETA2/2 embryos is
due in part to the absence of the transcription factor
goosecoid, whose expression in the pharyngeal arches, but
not in the limb buds, is disrupted in ETA2/2 embryos
(Clouthier et al., 1998). More recently, epithelial expression
of both ET-1 and Fgf-8 were found to be crucial for proper
patterning of the neural crest-derived ectomesenchyme in
the caudal and rostral halves of the first arch, respectively
(Tucker et al., 1999). Thus, the intercellular signaling
pathway mediated by ET-1/ETA interactions appears to be
important for either the migration of cephalic neural crest
cells or their subsequent differentiation in the arches during
epithelial–mesenchymal interactions, and this effect is me-
diated in part through specific transcription factors.
In an attempt to further elucidate the cellular basis of
craniofacial defects in ETA2/2 embryos, we have analyzed
pecific aspects of neural crest development. We find that
hile migration of neural crest cells into the arches of ETA
mutant embryos appears unaffected, the subsequent expres-
sion of at least five transcription factors by postmigratory
ectomesenchymal cells is disrupted. This indicates that
disruption of ETA signaling likely affects the later events of
proliferation or differentiation of neural crest derivatives,
rather than crest migration. Further, expression of the
factor Dlx-3 is disrupted in both the arch mesenchyme and
surrounding epithelium, suggesting a feedback loop in
which epithelium-derived ET-1 induces ETA signaling
ithin ectomesenchymal cells, which in turn results in the
aintenance of Dlx-3 expression in both the mesenchyme
nd the epithelium. In addition, ETA2/2 embryos have an
ncreased incidence of apoptosis in the developing first arch
esenchyme, indicating that in the absence of ETA-
dependent developmental patterning information, at least
some ectomesenchymal cells undergo programmed cell
death. These findings may help in understanding the mo-
lecular and cellular basis of certain classes of human
craniofacial malformations. p
Copyright © 2000 by Academic Press. All rightMATERIALS AND METHODS
Mice
Mice heterozygous for the targeted ETA allele (Clouthier et al.,
1998) were intercrossed in an inbred 129Sv background to produce
embryos, some of which were homozygous (ETA2/2) for the muta-
ion. Genotyping of embryos was also performed as previously
escribed (Clouthier et al., 1998).
In Situ Hybridization
Embryos for in situ hybridizations were collected and fixed in
4% paraformaldehyde overnight at 4°C. Whole-mount in situ
hybridizations were performed as previously described (Clouthier
et al., 1998) using digoxigenin-labeled riboprobes against dHAND
(Srivastava et al., 1997), eHAND (Srivastava et al., 1997), Dlx-2
Robinson and Mahon, 1994), Dlx-3 (Robinson and Mahon, 1994),
arx1 (Tissier-Seta et al., 1995), MHox (Cserjesi et al., 1992;
eussink et al., 1995), Hoxa-2 (Manley and Capecchi, 1995),
RABP-1 (Giguere et al., 1990), AP-2 (unpublished gift from T.
illimas), and Ufd1 (Yamagishi et al., 1999). Following whole-
ount in situ hybridization, embryos were dehydrated through a
raded series of ethanols, embedded in paraffin, and sectioned at 7
mm.
Apoptosis Analysis
E10.5 or E11.5 wild-type, ETA1/2, and ETA2/2 embryos were
ollected and fixed overnight in 4% paraformaldehyde. For each
ge, three ETA2/2 and three wild-type or ETA1/2 embryos were
xamined. After processing and embedding in paraffin, 4-mm serial
transverse sections through the first pharyngeal arch were cut and
collected on Plus-coated slides. Following examination of un-
stained slides, a span of nine slides was picked for subsequent
analysis. Slides 1, 4, and 7 were stained with hematoxylin and eosin
(Hosoda et al., 1994) and carefully examined to ensure that each
pair of embryos being compared matched in both embryonic age
and axial level. Embryonic age was assessed by counting the
number of somites as well as by overall appearance of the embryos.
The axial level chosen was through the first pharyngeal arch. While
arches of ETA mutant embryos are smaller and appear developmen-
tally delayed, the presence of specific structures was used to verify
axial level. These included the second pharyngeal pouch with the
entrance to the future tubotympanic recess apparent, internal
carotid arteries, and inferior ganglion of the vagus (X) nerve. No
gross or histological differences were observed between wild-type
and ETA1/2 embryos. Slides 2, 5, and 8 were subjected to a
dT-mediated dUTP nick end labeling (TUNEL) assay (Gavrieli et
l., 1992) using the Apoptosis Detection System (Promega) and
ollowing the instructions of the manufacturer. This kit uses
uorescein-12–dUTP to label the 39-OH ends of DNA, causing
poptotic nuclei to appear bright green when examined using
uorescence microscopy. The counterstain used was propidium
odide (Sigma) as recommended in the DNA Fragmentation Kit.
his stain results in nuclei that appear red when viewed under
uorescence microscopy. Consequently, apoptotic nuclei appear
ellow when a double exposure of the same section is taken. An
lympus BX-50 fluorescence microscope was used for analysis and
hotography.


















12 Clouthier et al.Quantitation of Apoptosis
To determine the apoptotic index observed in the first mandib-
ular arch (lateral lingual swelling) of E11.5 embryos, the number of
fluorescent nuclei within the first pharyngeal arch was counted,
being careful to take into account fragmentation of some apoptotic
nuclei. The total number of nuclei in the arch was then counted in
slides 1, 4, and 7, which had been stained by hematoxylin and
eosin. The apoptotic index is the total number of fluorescent nuclei
as a percentage of the total number of nuclei. Statistical signifi-
cance was determined using an unpaired Student’s t test
Bromodeoxyuridine (BrdU) Analysis
Pregnant ETA1/2 female mice were injected (ip) with 200 mg of
BrdU (Boehringer Mannheim) per kilogram body weight. One hour
later, embryos were collected, fixed in 4% paraformaldehyde for 1 h
at 4°C, and then processed for paraffin embedding. Five-
micrometer paraffin sections through the first pharyngeal arch
were collected on Plus-coated slides (Fisher Scientific), and every
other slide was counterstained with hematoxylin and eosin to
ensure that the sections examined matched those subjected to
TUNEL analysis. The chosen sections were then deparaffinized and
rehydrated, followed by DNA denaturation in 2 M HCl for 60 min
at 37°C. The acid was neutralized by immersing slides in 0.1 M
boric acid (pH 8.5), for 10 min. After being washed in PBS, sections
were permeabilized in 0.3% Triton X-100 in PBS for 10 min,
followed by three washes in PBS, each for 5 min. Sections were
blocked in 1.5% normal horse serum (Vector) in PBS, followed by
incubation with a monoclonal mouse anti-BrdU antibody (Boehr-
inger Mannheim) at a dilution of 1:25 in 0.1% BSA in PBS overnight
at 4°C. After being washed three times in PBS for 5 min each time,
sections were incubated with a biotinylated horse anti-mouse
antibody (Vector Laboratories) diluted to 1:2000 in 1% normal
horse serum in PBS for 30 min at room temperature. The slides
were washed three times in PBS for 5 min each time and then
incubated with a FITC–streptavidin antibody diluted to 1:50 in PBS
(pH 8.2) for 30 min in the dark. After being washed three times in
PBS for 5 min each, slides were counterstained with propidium
iodide (Sigma) and coverslipped using Vectabond mounting media
(Vector). Under fluorescence microscopy, BrdU-positive cells have
green nuclei, while all nuclei appear red from the propidium iodide.
Thus, BrdU-positive nuclei appear yellow when a double exposure
of the same section is taken. Negative controls included slides in
which no primary or secondary antibody was used.
RESULTS
Normal Migration of Cephalic Neural Crest Cells
in ETA
2/2 Mice
We have previously shown that the development of
cephalic neural crest derivatives is disrupted in ETA mutant
embryos (Clouthier et al., 1998), including the mandible,
Meckel’s cartilage, tympanic, gonial, jugal, alisphenoid,
pterygoid, and palatine bones, as well as the malleus, incus,
and hyoid. In situ hybridization studies showed that ETA
mRNA is not observed within the neural tube, indicating
that neural crest cells express ETA only after they begin
migration (Clouthier et al., 1998). Diffuse ETA message is
then found in streams extending away from the neural tube,
Copyright © 2000 by Academic Press. All rightresumably migrating neural crest cells, and in the head
esenchyme. Later, message is also observed in the ecto-
esenchyme of the pharyngeal arches. ET-1 message is
observed in the arch epithelium and core paraxial meso-
derm (Clouthier et al., 1998; Maemura et al., 1996). The
observed defects in ETA2/2 embryos could therefore arise as
result of aberrant migration of the crest cells or from a
ailure of subsequent epithelial–mesenchymal interactions
f ectomesenchymal cells within the arches.
We first examined the expression of several factors
nown to be expressed by migrating neural crest cells.
lx-2, a member of the Distal-less gene family, is involved
n the development of proximal skeletal elements derived
or arches 1 and 2 (Qiu et al., 1995, 1997). Using whole-
ount in situ hybridization analysis, Dlx-2-positive cells
ere observed extending from the posterior midbrain/
nterior hindbrain into arches 1 and 2 in both E9.0 wild-
ype and ETA2/2 embryos (Fig. 1A). Similar results were
obtained when we examined the expression of AP-2, a
transcription factor crucial to the survival of migratory
neural crest cells (Schorle et al., 1996; Zhang et al., 1996).
AP-2 expression in E9.0 wild-type and ETA2/2 embryos was
observed in streams extending from the rhombomere (r)1/r2
region into arch 1 and r4 into arch 2 (arrows in Fig. 1B).
CRABP-1, associated with early epithelial–mesenchymal
interactions within the pharyngeal arches, was weakly
expressed in the mesenchyme of arch 1 and strongly ex-
pressed in streams extending from the hindbrain into arches
2, 3, and 4 in both E9.0 wild-type and ETA2/2 mutant
embryos (Fig. 1C). Another marker of neural crest migration
into arch 2 is Hoxa-2, the most anteriorly expressed mem-
ber of the Hox gene family (Gendron-Maguire et al., 1993;
Rijli et al., 1993). Hoxa-2 expression in migrating crest cells
rom r4 was also unaffected by the disruption of the ETA
gene (Fig. 1D). Together, these results suggest that migra-
tion of neural crest cells from the posterior midbrain/
hindbrain regions into arches 1 and 2 is not detectably
affected by an absence of ETA-mediated signaling. However,
e cannot rule out a migratory disturbance in a small
ubset of neural crest cells.
Ectomesenchymal Expression of Dlx-2 and Dlx-3 Is
Abnormal in ETA Mutant Mice
Another possible effect of the absence of ETA signaling is
a disruption in the molecular cues provided by transcription
factors during the development of postmigratory neural
crest cells within the pharyngeal arches. Thus, we exam-
ined the expression of several transcription factors in the
developing arches at E9.5 and E10.5. We focused our anal-
yses on “positional” rather than “cell type” specific mark-
ers, as we had previously shown that there were no detect-
able defects in the fundamental patterning of neurogenic
neural crest derivatives in ETA2/2 embryos (Clouthier et al.,
1998).
























13Endothelin in Pharyngeal Arch DevelopmentDlx-22/2 embryos exhibit multiple craniofacial abnor-
malities (Qiu et al., 1995, 1997), while both Dlx-2 and
Dlx-3 are expressed in the mesenchyme and epithelium
of the arches (Robinson and Mahon, 1994; Qiu et al.,
1997). At E9.5, robust Dlx-2 expression in both wild-type
and ETA 2/2 embryos was observed in the mesenchyme
nd epithelium of the maxillary and mandibular compo-
ents of the first arch, as well as in arches 2, 3, and 4/6
Figs. 2A and 2B). In contrast, Dlx-3 expression, observed
n epithelial (arrows in Fig. 2D) and ectomesenchymal
ells in the mandibular component of arch 1 and all of
rch 2 of wild-type embryos, was almost undetectable
ithin both cell populations of E9.5 ETA 2/2 embryos
Figs. 2C and 2D).
At E10.5, Dlx-2 expression was observed in several
ocations, including arches 1, 2, and 3 in a pattern similar
o that observed in E9.5 embryos (Figs. 2E and 2F).
FIG. 1. Analysis of transcription factor expression in migrating neura
n situ hybridization. Pharyngeal arches 1 and 2 (1 and 2) are outlined
1/1) and mutant (2/2) embryos using a digoxigenin-labeled cRNA
xtending from rhombomere (r) 2 and r4 into arches 1 and 2 (arrowhea
gain, arrows point to migrating neural crest cells extending from r2
etected between wild-type and ETA2/2 embryos. (C) In both genotyp
n arches 2 and 3 (arrowheads), with weaker expression detected in the
2–r4 (brackets) and in streams extending from r4 into arch 2 (arrowh
etween wild-type and ETA2/2 embryos. h, heart; op, otic placode.owever, in E10.5 ETA 2/2 embryos, expression of Dlx-2 in d
Copyright © 2000 by Academic Press. All rightarch 2 was absent (Figs. 2E and 2F), indicating that ETA
signaling is required either for maintenance of Dlx-2
expression in arch 2 mesenchyme or for the maintenance
of the mesenchyme itself. Dlx-3 expression in E10.5
wild-type embryos was restricted to the posterior half of
arch 1 and all of arch 2, as well as in the epithelium of the
nasal process (Figs. 2G and 2H). In ETA 2/2 embryos, Dlx-3
expression was almost completely absent in the arch
mesenchyme and epithelium, although nasal epithelial
expression was unchanged (arrowheads in Fig. 2H). This
suggests that ETA signaling not only is necessary for
mesenchymal Dlx-3 expression but also acts in a recip-
rocal manner to maintain Dlx-3 expression in the arch
pithelium. It is also important to note that the sizes of
rches 1 and 2 were smaller in ETA mutant embryos at
10.5, a finding observed in all subsequent whole-mount
nalyses and one that is indicative of a developmental
t cells in E8.75–E9.25 ETA1/1 and ETA2/2 embryos using whole-mount
llow to aid in visualizing their boundaries. (A) Analysis of wild-type
for Dlx-2. Yellow arrows denote expression in migrating crest cells
both mutant and wild-type embryos. (B) Analysis of AP-2 expression.
into arches 1 and 2 (arrowheads); no observable differences could be
rong CRABP-1 expression is observed along the entire hindbrain and
mandibular arch mesenchyme. (D) Hoxa-2 expression is observed in







eadsefect in overall arch growth.
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14 Clouthier et al.FIG. 2. Developmental expression patterns of two Distal-less genes in ETA2/2 embryos. The pharyngeal arches in A, C, E, and G are again
outlined to aid with visualization. (A–H) Whole-mount in situ hybridization analysis using probes for Dlx-2 and Dlx-3 in E9.5 (A–D) and
E10.5 (E–H) wild-type (1/1) and mutant (2/2) embryos. (A and B) The expression of Dlx-2 in both the first and the second pharyngeal arches
is unchanged between wild-type and mutant embryos at E9.5. (C and D) Expression of Dlx-3 in both the mesenchyme (arrowheads in C and
D) and the epithelium (arrows in D) of arches 1 and 2 is almost completely absent in E9.5 ETA2/2 embryos. (E and F). At E10.5, Dlx-2


































15Endothelin in Pharyngeal Arch DevelopmentExpression of the HAND Genes Is Disrupted in
ETA Mutant Mice
The transcription factors dHAND (Srivastava et al., 1995)
and eHAND (Cserjesi et al., 1995) are expressed in both the
haryngeal arches and the conotruncal/outflow region of
he heart. dHAND mutant embryos die around E10.5, due
n part to the failure of aortic arch artery development
Srivastava et al., 1997) and apoptosis of all pharyngeal arch
esenchyme (Thomas et al., 1998). Further, the expression
f both genes is downregulated in ET-12/2 embryos (Thomas
et al., 1998). To examine whether this was also the case in
ETA2/2 embryos, whole-mount in situ hybridization analy-
is of dHAND and eHAND expression was examined. In
E9.5 wild-type embryos, dHAND was expressed on the
distal two-thirds of the first and second pharyngeal arches
(Figs. 3A and 3B), whereas eHAND expression was confined
to the distal one-third of the first arch (Figs. 3C and 3D). In
E9.5 ETA2/2 embryos, the expression of both genes was
nearly undetectable in the arches (Figs. 3A–3D).
At E10.5, expression of dHAND in wild-type embryos
was observed in the mesenchyme of arches 1–6 (Figs. 3E
and 3F). In ETA2/2 embryos, expression was almost com-
letely absent (Figs. 3E and 3F). However, histological
nalysis of sectioned embryos after whole-mount in situ
ybridization revealed that dHAND expression in mutant
mbryos was still slightly detectable within the distal
spects of the first arch mesenchyme (data not shown).
imilarly, expression of eHAND in E10.5 wild-type em-
ryos was unchanged from the pattern observed at E9.5, but
as significantly reduced in E10.5 ETA2/2 embryos (Figs. 3G
and 3H). However, like dHAND expression, eHAND mes-
age was still detectable along the extreme distal edge of the
rst arch in mutant embryos (Figs. 3G and 3H). Interest-
ngly, expression of dHAND in the bilateral dorsal aortas
appeared unaffected by loss of ETA signaling (yellow arrow-
heads in Fig. 3F), as was dHAND expression in the limb
buds (yellow arrowheads in Fig. 3E).
Disruption of Arch 2 Development Involves Loss of
Barx1 Expression
Like Dlx-2, another gene showing arch 2-specific changes
in expression was Barx1, a BarH family homeodomain
protein initially cloned in a screen of proteins capable of
binding to the Ncam promoter (Tissier-Seta et al., 1995). In
E10.5 wild-type mouse embryos, Barx1 was expressed in
the proximal aspects of the maxillary and mandibular
components of the first arch and in the second arch (Figs.
4A and 4B). In E10.5 ETA2/2 embryos, Barx1 expression in
xpression is still observed in the first arch of ETA2/2 embryos, but
f Dlx-3 in E10.5 ETA2/2 embryos is still almost completely absent
10.5 appears similar in wild-type and mutant embryos (arrowhead
o expose the pharyngeal arches.
Copyright © 2000 by Academic Press. All righthe first arch was unaffected, but expression in the second
rch was absent (arrows in Figs. 4A and 4B).
While we found that expression of a number of transcrip-
ion factors was aberrant in ETA2/2 embryos, that of others
was not. One gene recently implicated in the development
of cephalic neural crest cells is Ufd1, a gene that encodes a
protein involved in degradation of ubiquitinated proteins
(Yamagishi et al., 1999). Ufd1 was isolated in a PCR-based
subtraction screen for genes whose expression was dis-
rupted in dHAND mutant embryos (Srivastava et al., 1997;
Thomas et al., 1998). The human homolog, UFD1L, was
mapped to 22q11 and found to be deleted in all 182 patients
examined suffering from a CATCH 22 phenotype (Yamag-
ishi et al., 1999). Since Ufd1 is presumably downstream of
dHAND, it was assumed that its expression would be
disrupted in ETA2/2 embryos as well. However, we found
hat Ufd1 expression was unchanged in ETA2/2 embryos at
oth E9.5 (data not shown) and E10.5 (Figs. 4C and 4D),
ith expression observed in the frontonasal process, pha-
yngeal arches 1 and 2 (arrows and arrowheads in Figs. 4C
nd 4D), and limb buds. Though this is paradoxical, it does
ppear that Ufd1 acts on a craniofacial developmental
athway separate from that of the ETA receptor.
Another molecule whose expression was unchanged was
MHox, initially cloned in a screen of factors that bind the
muscle creatine kinase enhancer (Cserjesi et al., 1995).
MHox mutant mice have defects in multiple cephalic
neural crest-derived structures, indicating an involvement
in the development of the ectomesenchyme (Cserjesi et al.,
1995). In both E10.5 wild-type and ETA2/2 embryos, MHox
expression was observed throughout the first and second
arches (Figs. 4E and 4F), as well as in head and limb bud
mesenchyme.
Increased Apoptosis in the First Pharyngeal Arch
of ETA
2/2 Embryos
We have previously shown that numerous arch-derived
elements are either malformed or missing in E18.5 ETA2/2
embryos (Clouthier et al., 1998). While the results described
above suggest that disruption of normal transcription factor
expression leads to these defects, the cellular consequences
of these changes remain unknown. The size of the first arch
in E11.5 wild-type embryos is clearly larger than that in
ETA2/2 embryos (Figs. 5A and 5B). Further, the two first arch
halves in E11.5 ETA mutant embryos are not yet completely
fused, indicating a developmental defect. One possibility is
that ETA signaling results in altered proliferation of ecto-
mesenchymal derivatives. Alternatively, absence of ETA-
ediated developmental cues could lead to programmed
ow absent in the second arch (arrows). (G and H) Arch expression
ws in G), though expression along the nasal process epithelium at
). In frontal views (B, D, F, H), the heart has been removed in orderis n
(arro
s in Hs of reproduction in any form reserved.
db
16 Clouthier et al.FIG. 3. Developmental expression patterns of the HAND genes in ETA2/2 embryos. (A–H) Whole-mount in situ hybridizations using probes for
HAND and eHAND in E9.5 (A–D) and E10.5 (E–H) wild-type (1/1) and mutant (2/2) embryos. (A and B) Expression of dHAND in E9.5 ETA2/2
embryos is absent in arches 1 and 2 (arrows in A). (C and D) eHAND expression in E9.5 ETA2/2 embryos is also significantly reduced (arrows in
C). (E and F) At E10.5, dHAND expression is still greatly reduced in the arches of ETA2/2 embryos (arrows in E), though expression in the limb
ud (arrowheads in E) and dorsal aorta (arrowheads in F) appears normal. (G and H) Arch expression of eHAND is still greatly reduced in ETA2/2embryos (arrows in G and H).












17Endothelin in Pharyngeal Arch Developmentcell death of a subset of ectomesenchymal cells. To explore
these two possibilities, we analyzed the extent of prolifera-
tion and apoptosis within the mandibular component of the
first arch at E11.5.
We first looked for changes in the gross proliferation of
the mandibular arch mesenchyme at E11.5. When BrdU
incorporation was examined, an obvious decrease in the
number of labeled cells within the arches of ETA2/2 embryos
as observed (Fig. 5D). This was most notable in an area
xtending from the proximal arch into the distal arch in
TA2/2 embryos (arrows in Fig. 5D). Further, arch size of
FIG. 4. Expression of Barx1, Ufd1, and MHox in ETA2/2 embryos. W
utant (2/2) embryos. (A and B) Expression of Barx1 is observed in
in arch 2 of ETA2/2 embryos (arrows in B). (C and D) In contrast, Ufd
n the pharyngeal arches (arrows in C; arrowheads and arrows in D
nchanged in ETA2/2 embryos; the difference in staining intensity fomutant embryos was grossly smaller than that of wild-type
Copyright © 2000 by Academic Press. All rightmbryos, due in part to a 20% reduction in the total number
f cells present (Table 1). These findings suggest that at
east some ectomesenchymal cells have a reduced prolifera-
ive potential and may be the basis of the observed delayed
r underdevelopment of the first arch in ETA mutant
embryos.
We also examined the extent of apoptosis in the mandib-
ular arch at E10.5 and E11.5 using the TUNEL assay
(Gavrieli et al., 1992). At E10.5, apoptotic nuclei were
observed in the first arch of both wild-type and ETA2/2
embryos, most of which was associated with the normal
-mount in situ hybridization analysis of E10.5 wild-type (1/1) and
distal aspects of arches 1 and 2 in wild-type embryos, but is absent
ression is unchanged in ETA2/2 embryos, with expression observed
sal epithelium, and limb buds. (E and F) MHox expression is also
ox is due only to slight variations in exposure time to chromogen.hole
the
1 exp
), nadevelopment of the mandibular branch of the trigeminal (V)
s of reproduction in any form reserved.
18 Clouthier et al.FIG. 5. Proliferative and apoptotic changes in E11.5 ETA2/2 embryos. (A–F) Sections through the transverse plane of embryos at the level
of the mandibular component of the first pharyngeal arch. (A and B) Hematoxylin- and eosin-stained sections illustrate that the mandibular
arch (pa1) of ETA2/2 embryos is significantly smaller and developmentally delayed compared with that of wild-type embryos. Landmarks
used to define the axial level of the section are denoted, including the entrance of the future tubotympanic recess (asterisks) from
pharyngeal pouch 2 (pp2). The areas shown in C–F are indicated with black boxes. (C and D) Bromodeoxyuridine incorporation appears less
uniform in nuclei within the first arch of mutant embryos (D) than observed in wild-type embryos (C). This includes a band of nuclei in
the mutant arch that extends distally across the arch (arrows). (E and F) TdT-mediated dUTP nick end labeling assay for apoptosis in ETA1/1
and ETA2/2 embryos. Yellow fluorescent nuclei indicate cells undergoing apoptosis. Significant apoptosis is observed in the arch
mesenchyme of mutant embryos (arrows in F), whereas only scattered apoptotic cells are observed in the first arch of wild-type embryos
(arrow in E). Due to the delayed development of the pharyngeal arches in ETA2/2 embryos, normal apoptosis is still observed along the fusing
midline arch epithelium. These apoptotic cells were not included when calculating the apoptotic index (Table 1). aa1, aortic arch artery 1;
ca, carotid artery; opr, oropharyngeal region.


















19Endothelin in Pharyngeal Arch Developmentnerve (data not shown). However, by E11.5, there was a
nearly fourfold increase in the incidence of apoptosis in the
ectomesenchyme of ETA2/2 embryos (Table 1). While nor-
mal apoptosis was observed both in the pouch endoderm
and along the epithelial seam between the fusing arch
halves, an abnormal band of apoptotic nuclei was also found
in a portion of the ETA2/2 arch that corresponded to the area
that was BrdU deficient (Fig. 5D). Only a few apoptotic
nuclei were observed in the mesenchyme of wild-type
embryos (Fig. 5C). We believe that these results suggest that
the absence or reduction of many of the first and second
arch-derived structures in E18.5 ETA2/2 embryos is due in
art to apoptosis of the ectomesenchymal precursors.
DISCUSSION
Much of the head and neck skeleton arises from the
cephalic neural crest-derived ectomesenchyme of the pha-
ryngeal arches. The development of these structures is
mediated in part by complex interactions of multiple tran-
scription factors which are presumably programmed by an
intricate array of intercellular signaling events. In this
study, we have shown that the maintenance of expression
of at least six transcription factors within the arches re-
quires ETA-mediated cell–cell signaling, a finding sugges-
tive of a novel genetic pathway involved in craniofacial
development.
ETA Signaling Is Required by Postmigratory
Neural Crest Cells
Aberrant migration of cephalic neural crest cells leads to
craniofacial defects, as demonstrated in platelet-derived
growth factor-a receptor-deficient embryos (Soriano, 1997),
in which cephalic neural crest cells apparently undergo
apoptosis during migration. However, our results indicate
that cephalic neural crest cell migration is not significantly
different between wild-type and ETA mutant embryos.
These findings are also consistent with our finding that the
migration of cardiac neural crest cells is also normal in
ETA2/2 embryos (Yanagisawa et al., 1998a). Rather, absence
TABLE 1
Incidence of Apoptosis in the Lateral Lingual Swelling
Age (days) Genotypea Fluorescent nu
E11.5 1/1 or 1/2 17.9 6 2.4c
2/2 55.6 6 3.8*
a 1/1, 1/2, and 2/2 refer to wild-type, heterozygous, and hom
b The apoptotic index was obtained by dividing the number of
c Numbers represent means 6 standard error.
* P , 0.0001.
** P 5 0.0005.f ETA signaling appears to affect the proliferation/
Copyright © 2000 by Academic Press. All rightdifferentiation of postmigratory crest cells. However, vital
dye analysis of neural crest migration in ETA2/2 embryos
will be necessary to directly prove this point.
Hierarchical Transcription Factor Expression and
Pharyngeal Arch Development
The inductive processes that modulate pharyngeal arch
development are generally believed to be initiated by sig-
nals arising from the epithelium that act on ectomesenchy-
mal cells (Hall, 1982; Tyler and Hall, 1977). Such epithelial–
mesenchymal interactions within the pharyngeal arches
have been documented, including CRBP-1 and CRABP-1
(Gustafson et al., 1993), Msx-1 and Msx-2 (Hill et al., 1989;
MacKenzie et al., 1991), and BMP-2 and BMP-4 (Bennett et
al., 1995). Our present results suggest that interaction of
epithelial- and mesodermal-derived ET-1 with ETA-
xpressing ectomesenchymal cells results in signaling that
hen moderates the expression of at least six transcription
actors involved in head development. Figure 6 summarizes
ur findings by illustrating the sites at which specific
ranscription factors are expressed within the pharyngeal
rches and where this expression is dependent on ETA
signaling. From this it is clear that absent or reduced gene
expression is observed primarily in more distal areas of
arches 1 and 2, suggesting that ETA signaling is important
or subgroups of crest cell derivatives. This might be ex-
ected, considering that ET-1 expression is confined to the
pithelium of the distal half of the pharyngeal arches as
ell as the paraxial mesodermal core (Clouthier et al., 1998;
aemura et al., 1996). However, the expression of Dlx-2
nd Dlx-3, both observed in more proximal arch regions, is
lso affected. This may reflect the presence of paracrine
ediators of ETA signaling, a possibility further strength-
ned by the finding that maintenance of epithelial Dlx-3
xpression requires mesenchymal ETA signaling (see be-
low). Reliance on epithelial-induced mesenchymal signals
for continued epithelial development is not novel. Jernvall
et al. demonstrated that during tooth development
epithelial-derived BMP-4 expression is required for mainte-
nance of epithelial function, but is transduced through
mesenchymal signals (Msx-1 and Msx-2) (Jernvall et al.,
Total cells Apoptotic indexb
4609.7 6 150.5 0.0037 6 0.0004
3775.5 6 122.3** 0.0149 6 0.0013*
gous mutant ETA embryos.
escent nuclei by the number of total cells.clei
ozy
fluor1998). Whether the expression of other epithelial factors is








20 Clouthier et al.affected in ETA-deficient mice or what the nature of a
paracrine mediator might be is not yet known.
It is currently not clear how many signaling pathways
govern craniofacial development. Since Dlx-1, Hoxa-2, and
MHox are all properly expressed in ETA2/2 embryos, these
factors could either act upstream of ETA signaling or belong
FIG. 6. Expression domains of various transcription factors invol
signaling for initiation or maintenance of expression, whereas are
expression. Black areas depict domains where transcription factorto different or parallel genetic pathways governing pharyn-
Copyright © 2000 by Academic Press. All righteal arch development. The spatiotemporal expression pat-
erns of these molecules argues for the latter explanation.
hese additional pathways most likely work in concert
ith the ETA pathway in patterning the head, as mice
utant for Dlx-1 (Qiu et al., 1997), Hoxa-2 (Gendron-
aguire et al., 1993; Rijli et al., 1993), or MHox (Martin et
n craniofacial development. Areas depicted in red depend on ETA
own in blue are dependent on ETA signaling for maintenance of
ssion is independent of ETA signaling. L, limb bud.ved i
as shal., 1995) all share at least a subset of missing or deformed












































21Endothelin in Pharyngeal Arch Developmentelements with ETA2/2 embryos. It will be important to
examine the expression of other transcription factors as
well as ETA expression in Dlx-1, Hoxa-2, and MHox mutant
ice to address these questions further.
Proliferative and Apoptotic Changes in ETA
2/2
Embryos
One of the first observable morphological defects in
ETA2/2 embryos is reduced mandibular and hyoid arch size,
oticeable at E10.5. Our BrdU and TUNEL staining results
uggest that this may be partly due to slowed proliferation
f arch mesenchymal cells and their subsequent removal
hrough apoptosis. Increased ectomesenchymal apoptosis
ikely reflects a loss of normal environmental cues in
ctomesenchymal cells, rather than suggesting that ETA
signaling normally has a direct antiapoptotic effect. This is
based on the fact that significantly elevated apoptosis is not
observed until E11.5 in ETA2/2 embryos, even though ETA is
normally expressed as early as E8.5 (our unpublished data).
Yet, questions remain concerning how these changes are
brought about. One hypothesis is that the absence of
environmental cues (transcription factors) results in a stress
response which then results in both slowed progression
through S phase and later, apoptosis. p21, which inhibits
cell proliferation at the G1/S transition point (Harper and
lledge, 1996), has been shown to be involved in early tooth
emodeling during epithelial–mesenchymal interactions
Jernvall et al., 1998) and in mediating stress-induced pro-
iferative and apoptotic changes in vitro (Gorospe et al.,
996), so it is an attractive molecule to consider. It is also
ossible that the aberrant expression of cell cycle factors
hemselves leads to reduced proliferation and apoptosis.
nalysis of molecules associated with cell cycle control and
poptosis will have to be examined in ETA2/2 ectomesen-
chymal cells to determine if these possibilities are occur-
ring.
It is somewhat surprising that ectomesenchymal apopto-
sis is not more striking, considering the complex and
multifaceted craniofacial phenotype observed in ETA2/2
embryos (Clouthier et al., 1998). Further, absence of
dHAND expression in dHAND2/2 embryos resulted in
disruption of Msx-1 expression and massive apoptosis of
rch mesenchymal cells by E10.5 (Thomas et al., 1998).
hy then is arch apoptosis not more widespread in ETA2/2
embryos? Thomas et al. show that Msx-1 expression is
normal in ET-12/2 embryos and thus speculate that the
poptosis in dHAND mutant embryos results from absence
f Msx-1 expression. In their model, residual dHAND
xpression observed in ET-1-deficient embryos, similar to
he expression level observed in ETA2/2 embryos, is suffi-
ient to induce or maintain Msx-1 expression in ET-12/2
embryos and thus protect against ectomesenchymal apo-
ptosis. However, functional inactivation of Msx-1 in mice
does not result in widespread loss of arch-derived elements
(Satokata and Maas, 1994), implying that loss of Msx-1
alone does not result in ectomesenchymal apoptosis. Also, b
Copyright © 2000 by Academic Press. All righthe proposed action of Msx-1 during epithelial–
esenchymal interactions that occur during tooth develop-
ent suggests that absence of Msx-1 might actually have an
ntiapoptotic affect (Jernvall et al., 1998). Thus, this evi-
ence indicates that loss of Msx-1 expression alone does not
irectly correlate with ectomesenchymal apoptosis, though
he mechanism for its differential regulation in ET-12/2 (and
resumably ETA2/2) and dHAND2/2 embryos is not clear
(see below).
Scattered apoptosis in the mesenchyme of ETA mutant
embryos may reflect a differential dependence on ETA
signaling by subgroups of neural crest cells, possibly repre-
senting their rhombomeric origin (Kontges and Lumsden,
1996), and could explain the absence of Barx1, Dlx-2, and
truncated ETA transcripts only in the second arch. This may
also explain the fact that not all arch-derived elements are
missing in term embryos; many structures are simply
malformed. This may result from the action of other
signaling pathways that can partially compensate for the
loss of ETA signaling, preventing widespread apoptosis of
ctomesenchymal cells but not entirely rescuing their ab-
ormal development. Analysis of the developmental poten-
ial of ETA2/2 cells in ETA1/1 7 ETA2/2 chimeric embryos
may help clarify these points.
Possible Functions of Dlx-2, Dlx-3, and dHAND
Downstream of ETA Signaling
The differential change in Dlx-2 expression between the
first and the second arches of ETA2/2 embryos is intriguing
nd may provide insight into the role of Dlx-2 downstream
f ETA signaling. Dlx-22/2 mice exhibit abnormal develop-
ent of cranial bones derived from the proximal aspects of
rches 1 and 2, including the alisphenoid and maxillary
ones (arch 1) and the stapes and styloid (arch 2) (Qui et al.,
1995). Dlx-2 is thus believed to be crucial for proper
proximodistal patterning of the arches. While absence of
ETA signaling affects most arch-derived elements
(Clouthier et al., 1998), distal structures of the first arch are
more severely affected, with most being completely absent
(i.e., Meckel’s cartilage, the mandible, and the malleus).
This correlates with higher epithelial ET-1 expression in
the medial–distal aspects of the arch (Maemura et al.,
1996). This does not, however, explain the loss of Dlx-2
expression in the second arch, which suggests that ETA
signaling is either directly or indirectly inducing a second
arch-specific mediator of Dlx-2 expression. It is interesting
that the major phenotypic overlap between Dlx-22/2 and
TA2/2 embryos is severe malformation or absence of the
tapes and styloid. Thus, this may represent a signaling axis
nvolved in patterning of these two craniofacial structures.
The effects of Dlx-3 absence in ETA2/2 embryos are more
difficult to assess due to the early embryonic lethality of
Dlx-32/2 embryos (Morasso et al., 1999). Like Dlx-2, Dlx-3
s expressed in the proximal aspects of arches 1 and 2, with
rst-arch expression becoming restricted to the caudal half
y E10.0 (Robinson and Mahon, 1994). This caudal restric-








































22 Clouthier et al.tion resembles a pattern observed for a subpopulation of
cephalic crest cells derived from rhombomeres 1 and 2
(Lumsden et al., 1991). Long-term fate mapping analysis
indicates that this subpopulation eventually forms the
incus (Kontges and Lumsden, 1996). Thus, Dlx-3 may be
involved in incus development, and downregulation of
Dlx-3 expression as a direct or indirect consequence of loss
of ETA receptor signaling in ETA2/2 embryos may therefore
ontribute to the absence of the incus. The expression
attern of Dlx-3 in the second arch indicates that it may be
nvolved with Dlx-2 in the development of the stapes and
styloid.
Another interesting aspect of Dlx-3 expression is that it is
not only absent in the mesenchyme, but is also greatly
reduced in the arch epithelium of ETA2/2 embryos. During
rch development, proliferation of the ectodermal epithe-
ium occurs concomitantly with ectomesenchymal prolif-
ration, ensuring proportional growth. Growth and mainte-
ance of the epithelium also have a more direct impact on
ead development, as the ectoderm is believed to be in-
olved in the development of the cephalic neural crest-
erived dermal bones, including the jugal and squamosal
ones (Tyler and Hall, 1977), two bones that are malformed
n ETA2/2 embryos (Clouthier et al., 1998). Epithelial expres-
sion of Dlx-3 has been hypothesized to be involved in
dermal bone development (Qiu et al., 1997), and its absence
may thus be a major contributing factor to dermal bone
deformities observed in ETA2/2 embryos. Interestingly, a
utation in DLX-3 has recently been found to be associated
ith trichodento-osseous syndrome in humans, an autoso-
al dominant disorder primarily affecting the teeth and
ranial bones (Price et al., 1998). The sites of this disease
ccur in areas in which significant epithelial–mesenchymal
nteractions occur during development, illustrating the
mportance of Dlx-3 in epithelial–mesenchymal interac-
ions during head development.
Another interesting relationship is that of ETA and
HAND. Although normal dHAND expression is depen-
ent on ETA signaling, and expression of both Ufd1 and
Msx-1 is dependent on dHAND, we and others (H. Kurihara,
personal communication) have found that Ufd1 expression
is intact in ET-12/2 and ETA2/2 embryos, as is Msx-1 expres-
ion in ET-12/2 embryos (and thus presumably in ETA2/2
embryos) (Thomas et al., 1998). This is despite the fact that
UFD1L mutations in humans (CATCH 22) result in a
phenotype that closely resembles that of ETA2/2 embryos
Clouthier et al., 1998; Yamagishi et al., 1999). We cur-
rently do not understand the basis of these discrepancies,
though the cardiac insufficiency observed in dHAND mu-
tant embryos that leads to death at E11.0 may contribute to
changes throughout the embryo, including the heart and
pharyngeal arches. These changes would likely include the
loss of expression of numerous genes, many of which would
not necessarily lie directly downstream of dHAND. In
contrast, while loss of ETA signaling disrupts cephalic and
cardiac neural crest cell development, embryonic lethality
is not observed. Therefore, widespread changes in gene
Copyright © 2000 by Academic Press. All rightxpression would not be expected. That Ufd1 expression is
ormal in ETA2/2 embryos also illustrates the complex
ombinatorial pathways that are required for correct cranio-
acial patterning and suggests that other 22q11 genes may
ct downstream of ETA signaling. Further analysis of Msx-1
nd Ufd1, as well as other downstream signaling molecules
f ETA and dHAND, will be necessary to better understand
hese processes.
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